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Abstract 
BACKGROUND: Thalassemia is one of the most common genetic health problems in the world. More than 200 
different mutations have been identified in the beta-globin gene and among the 24 β-globin gene mutations in β-
thalassemia carriers in the north of Iran IVSII-I G>A mutation has the highest frequency. Using fast, inexpensive, 
simple and reliable methods for the detection of the mutations in β-thal carriers is very important in prenatal 
diagnosis, and introduction of alternative methods to the existing ones can help to simplify the detection of 
mutations. Since its introduction, different methods derived from LAMP have been widely used for SNPs 
detection.  
AIM: This study was aimed to design a new method for the detection of IVSII-I G>A mutation on β-globin gene 
based on AS - LAMP technique.  
METHODS: Primer explorer V5 software was used for the design of LAMP primers. Three sets of primers were 
designed. In the first set, the BIP primers were exactly complementary to the normal and mutant alleles. In the 
second set, 1 nucleotide (T) was inserted at the 5’ end of BIP primers, and in the last set, one nucleotide at the 5’ 
end of BIP primer was changed. The other required primers for the LAMP reaction (FIP, B3, and F3) were the 
same for all 3 sets of primers. The LAMP reaction was applied on three DNA samples (Wild type, Heterozygote 
and Homozygote for IVSII-I G>A mutation) and synthetic DNA. 
RESULTS: The results of the present study showed that LAMP reaction using three sets of primers could not 
successfully detect the IVSII-I G > A mutation among subjects DNA sample and synthetic DNA. 
CONCLUSION: Although several studies have successfully used ARMS-LAMP method to detect the SNPs, and 
other studies use a variety of methods to identify IVSII-I G>A mutation, the present study was unable to 
differentiate between a normal allele and IVSII-I G>A mutation. Hence further studies are recommended to 
consider redesigning of primer set, DNA concentration and using commercial LAMP Master Mix to detect the 
mutation. 
 
 
 
 
 
 
Introduction 
 
Thalassemia is one of the most common 
genetic health problems in the world resulting from the 
reduced or absent synthesis of the haemoglobin 
chains synthesis. Thalassemias are classified into two 
main types of α- or β based on the absence 
production of α- or β-globin chains. β-thalassemia is 
caused by inherited mutations on the β-globin gene 
that leads to reduced synthesis of the β-globin chain 
of the haemoglobin. The highest frequency of β-
thalassemia mutations is reported from Mediterranean 
countries, the Middle East, and East Asia. More than 
200 different mutations have been identified in the 
beta-globin gene, causing wide genotypic and 
phenotypic variability of this blood disorder [1], [2]. 
Alpha and beta thalassemia mutations are 
very common in Iran [3], and the highest prevalence 
of β-Thalassemia (around 10%) has been reported 
from north of Iran, in Southern coastlines of Caspian 
Sea, and South of Iran close to the Persian Gulf. The 
prevalence of β-thalassemia mutations in most parts 
of the country has been estimated to be 4-8% [4], [5], 
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[6]. Overall, there are 20,000 affected β-thalassemia 
patients and 3,750,000 carriers of the diseases in Iran 
[7]. Among the 24 β-globin gene mutations in β-
thalassemia carriers in the north of Iran IVSII-I G>A 
mutation has the highest frequency (61%) [8].  
The national program for the prevention of 
thalassemia in Iran has been started since 1997. This 
premarital screening program is compulsory in all 
provinces, and all couples should be screened before 
they get married. The aim of this program is screening 
β-thal carriers and preventing the child-birth with β-
thal major [9], [10], [11]. Since in lots of the cases in 
screening program the mutations of the carriers must 
be identified, using fast, inexpensive, simple and 
reliable methods for the detection of the mutations in 
β-thal carriers is very important in prenatal diagnosis, 
and introduction of alternative methods to the existing 
ones can help to simplify the detection of mutations.  
For the identification of the mutations among 
β-thal carriers, PCR-based methods are usually used. 
Although PCR-based methods are cost-effective 
techniques that are very robust for nucleic acid 
amplification, they cannot be performed in every lab. 
Also, the methods require a thermocycling system, 
which limits their application in the field. There are few 
genetic laboratories that collaborate with the 
screening programs to detect the mutations among 
carriers and patients. 
In the past years, numerous nucleic 
amplification approaches have been introduced that 
do not need the thermocycling system. Isothermal 
techniques to amplify nucleic acids include loop-
mediated isothermal amplification (LAMP), nucleic 
acid sequence-based amplification (NASBA), 
helicase-dependent amplification (HDA), rolling circle 
amplification (RCA), multiple displacement 
amplification (MDA), and recombinase polymerase 
amplification (RPA); these new approaches can easily 
be used at a constant temperature [12], [13], [14], 
[15], [16], [17], [18], [19]. 
The LAMP method was first introduced by 
Notomi et al., in 2000 [20]. Since then, different 
methods derived from LAMP have been widely used 
for pathogen detection [21], [22], [23], [24]. 
The LAMP method uses four sets of primers 
that are specially designed to identify six distinct 
regions on the objective gene. These sets of primers 
are the outer and inner primers (F3 and B3). The 
forward inner primer (FIP) consisting of the F2 zone at 
the 3' end with the sequence similar to the F1c region 
at the 5' end, is complementary to the F2c zone, while 
the backward inner primer (BIP) consisting of the B2 
zone at the 3' end with the sequence similar to the 
B1c region at the 5' end, is complementary to the B2c 
zone (Figure 1). The two primers are complementary 
to the downstream zone of the opposite strand in the 
objective region (F1 and B1) [20]. 
 
Figure 1: Schematic view of LAMP Primers Using 4 sets of Primers. 
These sets of primers are the outer and inner primers (F3 and B3). 
The forward inner primer (FIP) consisting of the F2 zone at the 3' 
end with the sequence similar to the F1c region at the 5' end, is 
complementary to the F2c zone, while the backward inner primer 
(BIP) consisting of the B2 zone at the 3' end with the sequence 
similar to the B1c region at the 5' end, is complementary to the B2c 
zone 
 
The LAMP method yields a substantial 
amount of amplicons in a short time (around 60 min), 
which is 103 times higher than the amount produced 
with PCR [25]. 
Because the LAMP method uses four primers 
sets that are specific to the objective regions, it has 
rapid amplification, a higher amount of amplification 
products, and smaller detection limits compared with 
PCR-based methods [23]. Hence, LAMP is more 
beneficial for point-of-care testing (POCT) than PCR 
[24]. 
The LAMP-based methods have rarely been 
used for genotyping and detecting point mutations. 
Thus, designing new LAMP methods capable of 
genotyping could be an alternative method to other 
genotyping techniques. Moreover, the LAMP 
technique is a very suitable, easy to use, and cost-
effective approach for POCT or on-site testing. This 
study was aimed to design a new method for the 
detection of IVSII-I G>A mutation on β-globin gene 
based on AS (Allele-Specific)-LAMP technique.  
 
 
Material and Methods 
 
Among the registered patients at the 
thalassemia research centre, Mazandaran University 
of medical sciences, the cases that were heterozygote 
and homozygote for IVSII-I G>A mutation were 
selected. The mutation in patients was detected using 
standard ARMS-PCR method and confirmed with 
PCR-sequencing. The genomic DNA was extracted 
from peripheral blood applying QIAamp DNA Micro Kit 
(Qiagen, USA). 
Some healthy subjects with no mutations on 
the β-globin gene were also selected with the help of 
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PCR-sequencing method. Synthetic DNAs 
complementary to the wild type and mutated region 
were also designed. 
 
Primer designing for AS-LAMP 
For primer designing Primer explorer V5 
software, which is a specific tool for the design of 
LAMP, primers were used (Table 1), and 
NM_000518.4 reference sequence was considered as 
a template. To select the primers that could 
successfully differentiate the IVSII-I G>A mutation (dB 
SNP rs#:33945777) from normal allele, three sets of 
primers were designed. In the first set, the BIP 
primers were exactly complementary to the normal 
and mutant alleles. In the second set, 1 nucleotide (T) 
was inserted at the 5’ end of BIP primers, and in the 
last set, one nucleotide at the 5’ end of BIP primer 
was changed. The other required primers for the 
LAMP reaction (FIP, B3, and F3) were the same for all 
3 sets of primers (Table 1).  
Table 1: The sequences of primers used for AS-LAMP method 
for the detection of IVSII-I G>A method  
Set1: BIP-Wild = B1C (5-3) + B2 (5-3) GTGAGTCTATGGGACGCTTGATTATCCCCTTCCTATGACATGA 
Set1: BIP-Mutated = B1C M (5-3) + B2 (5-3) ATGAGTCTATGGGACGCTTGATTATCCCCTTCCTATGACATGA 
Set 2: BIP-Wild = B1C (5-3) + B2 (5-3) GTTGAGTCTATGGGACGCTTGATTATCCCCTTCCTATGACATGA 
Set2: BIP-Mutated = B1C M (5-3) + B2 (5-3) ATTGAGTCTATGGGACGCTTGATTATCCCCTTCCTATGACATGA 
Set3: BIP-Wild = B1C (5-3) + B2 (5-3) GTCAGTCTATGGGACGCTTGATTATCCCCTTCCTATGACATGA 
Set3: BIP-Mutated = B1C M (5-3) + B2 (5-3) ATCAGTCTATGGGACGCTTGATTATCCCCTTCCTATGACATGA 
FIP= F1C (5-3) + F2 (5-3) CCTGAAGTTCTCAGGATCCACGCCTTTGCCACACTGAGTG 
F3 TCACCTGGACAACCTCAA 
B3 5’CCATTCTAAACTGTACCCTG3’ 
Set1: primer designed by http://primerexplorer.jp/lampv5e/index.html, Set2: In this sets of 
primers 1 nucleotide was inserted at the 5' end of BIP primers, Set3: The sequence of 
primers in which one nucleotide at the 5' end of BIP primer was changed 
 
PCR-Sequencing reaction with B3 and F3 
 primers 
To find that the primers could amplify the 
target region PCR reaction with the help of F3 and B3 
primers were applied, and the PCR product was 
sequenced using ABI Capillary system.  
 
AS-LAMP reaction 
Conventional LAMP mix in total volume of 
20µL that contained 2 µL of 10 X Bst DNA polymerase 
reaction buffer (New England Bio-labs), 8 mM MgSo4, 
0.8 M betaine, 1.4 mM of each dNTPs, 1.6 mM FIP, 
1.6 mM BIP (wild or Mutated), 0.2 mM B3, 0.2 mM F3 
and 8U Bst DNA polymerase (New England Bio-labs). 
The master mix was dispensed in each microtube, 
and 50 ng from the DNA template was added to the 
mixtures. Then the reaction mixes were incubated at 
60°C for 60 min. It should be mentioned that for each 
sample, two LAMP reactions were done, one with wild 
primers and another with Mutated primer. The LAMP 
products were run on 1% agarose gel.  
 
 
 
Results 
 
PCR sequencing 
The results of PCR sequencing with the help 
of F3 and B3 primer showed that the primers could 
successfully amplify the target region on the beta-
globin gene (Figure 2). 
 
Figure 2: The results of PCR-Sequencing using F3 and B3 primers 
for the identification of IVSII-I G > A mutation: from left to right: 
Homozygote wild type, Heterozygote, Homozygote mutated 
 
LAMP reaction with the first primer set 
The LAMP reaction using first sets of primers 
(without any modification) showed that the primers 
could amplify the target DNA, but this set of primer 
was unable to differentiate the normal allele from 
mutated one (Figure 3). 
 
Figure 3: The results of AS LAMP reaction using primers without 
any modification; 1) Ladder 100bP; 2) Normal DNA with wild type 
primer; 3) Normal DNA with mutant type primer; 4) Mutant  
DNA (Homozygote) with wild type primer; 5) Mutant DNA 
(Homozygote) with mutant type primer; 6) Heterozygote DNA with 
wild type Primer; 7) Heterozygote DNA with mutant type primer; 8) 
blank 
 
LAMP reaction with second primer set 
 (with a nucleotide insertion) 
Like the LAMP reaction with the modified 
primers that a nucleotide (T) was inserted one 
nucleotide before mutation site at the 5 ends of BIP 
primers indicated that these primers could not 
differentiate the normal DNA from the mutant one 
(Figure 4). 
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Figure 4: The results of AS LAMP reaction using primers with a T 
insertion; 1) Ladder 100bP; 2) Normal DNA with wild type primer; 3) 
Normal DNA with mutant type primer; 4) Mutant DNA (Homozygote) 
with wild type primer; 5) Mutant DNA (Homozygote) with mutant 
type primer; 6) Heterozygote DNA with wild type Primer; 7) 
Heterozygote DNA with mutant type primer; 8) blank 
 
LAMP reaction with third primer set (with a 
 nucleotide substitution at the third 
 nucleotide before mutation site) 
The results of LAMP reaction using the third 
set of primers with a nucleotide substitution at the 
third nucleotide before mutation site indicated that the 
LAMP reaction could not successfully distinguish the 
mutant and normal alleles (Figure 5). 
 
Figure 5: The results of AS LAMP reaction using primers with a 
nucleotide substitution at the third nucleotide before mutation site; 
1) Ladder 100bP; 2) Normal DNA with wild type primer; 3) Normal 
DNA with mutant type primer; 4) Mutant DNA (Homozygote) with 
wild type primer; 5) Mutant DNA (Homozygote) with mutant type 
primer; 6) Heterozygote DNA with wild type Primer; 7) Heterozygote 
DNA with mutant type primer; 8) blank with wild primer; 9) blank 
with mutant type primer 
 
The gradient of mgso4 and betain for 
 LAMP reaction 
 The gradient of mgso4 (8-10-12-16 mM (and 
betain (0.8-1.6 -2.4-4.8 M) was separately applied to 
Optimize LAMP reaction, and the results showed that 
different concentration of these materials was unable 
to distinguish the mutant and normal alleles.  
 
Discussion 
 
Since the introduction of the LAMP approach, 
most of the studies have been applying the 
conventional type of this technique to detect the 
desired segment of DNA of the pathogens. However, 
some studies have used this method for genotyping 
and detection of the SNPs. These studies argued that 
the AS-LAMP method is a valid method for the 
detection of the SNPs. the present study aimed to 
detect the IVSII-I GA mutation which is the most 
frequent mutation among β- thalassemia patients in 
the north of Iran.  
In the ARMS-LAMP method, two sets of 
LAMP primers are designed to differentiate two 
different nucleotides at the same position in the target 
DNA: BIP or FIP primers which are specifically 
designed complementary to the mutation point at the 
3' end of the B2 primer (5' end of the BIP primer). The 
remaining primers, F3, B3, and FIP or BIP, are 
common for each primer set. Two LAMP reactions 
should be prepared with each set of primers for each 
sample.  
Several studies have used the AS-LAMP 
method for SNP detection. For instance, this method 
was used for the identification of the West African kdr 
(kdr-w; L1014F) [26]. And G119S ace-1R mutations 
[27] in field-collected Anopheles gambiae. 
Yongkiettrakul et al., (2017) designed an SNP-LAMP 
assay to detect the N51I mutation on the dhfr gene 
that is associated with pyrimethamine resistance in 
Plasmodium falciparum with 100% specificity [28].  
Ikeda et al. in 2007, designed an ARMS-
LAMP approach for the identification of L858R 
mutation on the epidermal growth factor receptor gene 
(EGFR) [29]. They used an in situ LAMP in which The 
FIP and BIP primers were labelled with fluorescein 
isothiocyanate (FITC) for mutation detection on 
paraffin-embedded tissues.  
In 2017, Tamura et al., Used the ARMS-
LAMP method to detect the N526K mutation in the ftsI 
gene that was involved in H. pylori-resistant 
Haemophilus influenza with a negative effect on 
ampicillin beta-lactamase. Using this method, they 
succeeded in identifying this mutation in the 
mentioned species [30]. 
Using the AS-LAMP method, Duan et al., in 
2016, identified spot mutations (TTC → TAC, F200Y) 
in the β2-tubulin gene, which is involved in resistance 
to benzimidazole in Fusarium asiaticum fungus. The 
comparison between the results of this method with 
the PCR test showed that this method could 
successfully detect this mutation in resistant strains of 
agricultural products [31]. 
β-thalassemia is the most common 
haemoglobin disorder in Iran and IVSII-I GA 
mutation is the most frequent mutation in the north of 
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Iran. Several studies have introduced a variety of 
methods for the identification of this mutation. Zafari et 
al., in 2010 developed the real time HRM (High-
Resolution Melting) method in which they identified 
the mutation IVSII-I GA on serum samples of 
pregnant mothers. The purpose of the research was 
to detect the fetus's IVSII-I GA mutation in the 
serum of pregnant mothers. The sensitivity and 
specificity of the introduced method were 92.6% and 
82.6%, respectively [32].  
Heidari Sharafkhalkali et al., in 2017, using a 
Ligation Assay method combined with Nanoparticles 
could successfully identify the IVSII-I GA mutation. 
They used probes that were labelled with magnetic 
nanoparticles and quantum dots. In the mentioned 
study, two types of the probe were designed, one 
complementary to the normal region and another 
complementary to the mutant area. Fifteen 
homozygote and 21 heterozygote patients were 
successfully identified using this method [33]. 
Hamid et al., in 2012 have also used the HRM 
(High Resolution Melting) method to identify 4 
common mutations in Iran including IVSI-5 (G>C), 
CD36/37 (-T), IVSII-I (G>A), IVSI-110 (G>A). 
However, in the IVSII-I GA mutation, 2 peaks were 
observed due to the presence of a polymorphism 
close to mutation site [34]. 
Multiplex HRM method to identify common 
beta-globin gene mutations in Greece was also 
developed by Chassanidis et al., in 2016. They 
designed several primers for mutation sites. Several 
mutations, including IVSII-I, in multiplex conditions, 
were simultaneously amplified [35]. 
Haji Hosseini et al., in 2015, using Tetra-
Primer ARMS PCR method could detect IVSII-I GA 
and FSC 8/9 InsG mutations in 30 affected beta-
thalassemia patients in Isfahan province. This method 
has been able to differentiate normal, heterozygous, 
and homozygous samples in patients with 100% 
specificity and reliability. The frequency of IVSII-I 
GA and FSC 8/9 InsG mutations in Isfahan province 
were 86.6% and 16.6 % respectively [36]. 
Honardoost et al., in 2014, compared the 
results of Tetra Primer ARMS PCR method with 
conventional ARMS PCR technique to detect IVSII-I 
mutation in β-thalassemia patients. The PCR-
sequencing approach was considered as a standard 
gold test. Fifty-seven subjects, including 2 
homozygous, 49 heterozygotes, and 6 normal 
samples were analysed using both techniques. They 
reported that Tetra Primer ARMS-PCR was able to 
detect IVSII-I mutation with 100% sensitivity and 
specificity while the conventional ARMS test had a 
specificity and sensitivity of 100% and 92.55% [37]. 
In 2015, Alfdali et al., identified common β-
globin gene mutations in Egypt using Reverse Dot-
Blot method among 40 β-thalassemia patients. Using 
PCR sequencing as a standard gold method, the 
results showed that this method had a sensitivity of 
92.5% [38].  
Although the mentioned studies have 
successfully used ARMS-LAMP method to detect the 
SNPs, and other studies use a variety of methods to 
identify IVSII-I GA, the present study was unable to 
differentiate between a normal allele and IVSII-I GA 
mutation. At the present study, three different primer 
sets could not detect the mutation in the patient's DNA 
and synthetic DNA. Hence further studies are 
recommended to consider redesigning of primer set, 
DNA concentration and using commercial LAMP 
Master Mix to detect the mutation.   
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